Updated Balance Requirements in the Pharmaceutical Industry
Laboratory balance requirements across global pharmacopeias have been significantly revised to improve clarity, harmonization, and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddy’s submits Abatacept Biosimilar BLA to USFDA for review
351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid arthritis, psoriatic arthritis and pJIA
Morepen Laboratories secures ₹825 Cr CDMO mandate from global pharma company
Multi-year contract to commence supplies within 4–5 months, execution planned through Q1 of next financial year
Global Pain Therapeutics market shows scope for non-opioid Innovation: GlobalData
Report highlights voltage-gated sodium channel inhibitors, pipeline trends and regulatory incentives in pain treatment
Queensland delegation concludes BioAsia 2026 mission to expand India–Australia life sciences ties
TIQ and Austrade engage with Indian biotech, clinical trials and MedTech stakeholders during Hyderabad and Bengaluru visit
Cadila Pharmaceuticals marks 100th birth anniversary of Founder Chairman Indravadan Modi
Company commemorates centenary of founder and recalls his role in building India’s pharma manufacturing base
When companies break bad: Directors’ liability under Drugs and Cosmetics Act, 1940
Vineet Unnikrishnan and Sonu Bhasi, Cyril Amarchand Mangaldas; examine the scope of directors’ liability and vicarious…
Zydus Lifesciences launches Anyra, biosimilar of Aflibercept 2 mg in India
Company signs agreement with Regeneron Pharmaceuticals and Bayer for ophthalmic therapy
Dr Reddy’s Laboratories acquires Progynova and Cyclo-Progynova trademarks from Mercury Pharma for…
Acquisition strengthens gynaecology portfolio and marks entry into hormone replacement therapy segment
DFE Pharma launches Continuous Manufacturing platform in collaboration with Gericke
Platform integrates CM-ready excipients, testing environment and process expertise